CRISPR Therapeutics $2.4 Billion Cash: Why the Stock Slump Persists
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Identify bond funds that offer tax-exempt income in retirement and how to incorporate them for tax-efficient withdrawals.
23,934 articlesCRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Bitcoin, Ethereum, and XRP flashed potential buy signals after a wide market drop, according to on-chain analytics. A...
eXp Realty has promoted Wendy Forsythe to chief operating officer, marking a strategic shift as the cloud brokerage s...
Investors are watching Apple’s latest Siri reveal to see if it marks a meaningful AI leap or just another upgrade. Th...
As employers rethink wellness benefits, workers weigh B12's energy promise against testing costs and coverage gaps, s...
Figure Technology Solutions agrees to purchase Kiavi for $717 million, expanding first-lien volume by about 40% and b...
May wholesale prices rose again for the second straight month, marking the largest back-to-back gain since 2022 and s...
Industry lenders are speeding toward AI-driven processes in reverse mortgage operations, but legal experts warn that ...
Federal safety regulators are recalling more than coffee makers—about 17,600 Kidisle units—after reports of hot liqui...
SpaceX gears up for the largest IPO in history on Nasdaq, while a 1:1 tokenized SpaceX equity trades on Solana. Backp...
A sharp drop in a space-focused stock can spark questions about risk and timing. This guide breaks down the real reas...
When a veteran value investor piles into a beaten-down name, traders take notice. Prem Watsa recently added to his Un...